Telogen Effluvium: Potential Causes in Iraq

    Image of study
    TLDR Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.
    The study conducted from March 2014 to June 2015 aimed to identify the main risk factors of Telogen Effluvium (TE), a common hair loss problem among women, in Thi-Qar Province, Iraq. The study involved 100 women with TE and 100 healthy controls. The researchers measured the levels of Thyroid Stimulating Hormone (TSH), serum Ferritin, and Vitamin D3 in both groups. The results showed a significant association between a positive family history of hair loss and women with TE. However, no significant difference was found in TSH levels between the two groups. The study found significantly lower serum Ferritin and Vitamin D3 levels among women with TE. The conclusion of the study was that low serum Ferritin and Vitamin D3 levels might play a major role in the etiology of TE.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 404 results

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Is DUT better or worse than FIN?

      in Finasteride/Dutasteride  62 upvotes 1 year ago
      The conversation discusses the effectiveness of Dutasteride (DUT) and Finasteride (FIN) for hair loss. Users share varied experiences, with some finding DUT more effective and others experiencing side effects or no change, highlighting that individual responses can vary.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Similar Research

    6 / 1000+ results